177 related articles for article (PubMed ID: 26089880)
1. Resistance to the Beneficial Metabolic Effects and Hepatic Antioxidant Defense Actions of Fibroblast Growth Factor 21 Treatment in Growth Hormone-Overexpressing Transgenic Mice.
Boparai RK; Arum O; Miquet JG; Masternak MM; Bartke A; Khardori RK
Int J Endocrinol; 2015; 2015():282375. PubMed ID: 26089880
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
3. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.
So WY; Cheng Q; Xu A; Lam KS; Leung PS
Cell Death Dis; 2015 Mar; 6(3):e1707. PubMed ID: 25811804
[TBL] [Abstract][Full Text] [Related]
4. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
5. Role of Fibroblast Growth Factor 21 (FGF21) in the Regulation of Statural Growth.
Grunwald T; De Luca F
Curr Pediatr Rev; 2015; 11(2):98-105. PubMed ID: 26133178
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.
Inagaki T; Lin VY; Goetz R; Mohammadi M; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2008 Jul; 8(1):77-83. PubMed ID: 18585098
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism.
Caixeta LS; Giesy SL; Krumm CS; Perfield JW; Butterfield A; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11597-11608. PubMed ID: 31548064
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5.
Yu J; Zhao L; Wang A; Eleswarapu S; Ge X; Chen D; Jiang H
Endocrinology; 2012 Feb; 153(2):750-8. PubMed ID: 22166977
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
11. Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans.
Lundberg J; Höybye C; Krusenstjerna-Hafstrøm T; Bina HA; Kharitonenkov A; Angelin B; Rudling M
J Intern Med; 2013 Sep; 274(3):227-32. PubMed ID: 23844970
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
[TBL] [Abstract][Full Text] [Related]
13. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding.
Loyd C; Magrisso IJ; Haas M; Balusu S; Krishna R; Itoh N; Sandoval DA; Perez-Tilve D; Obici S; Habegger KM
J Appl Physiol (1985); 2016 Sep; 121(3):687-98. PubMed ID: 27445299
[TBL] [Abstract][Full Text] [Related]
15. Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses.
Salminen A; Kaarniranta K; Kauppinen A
Ageing Res Rev; 2017 Aug; 37():79-93. PubMed ID: 28552719
[TBL] [Abstract][Full Text] [Related]
16. Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes.
Guasti L; Silvennoinen S; Bulstrode NW; Ferretti P; Sankilampi U; Dunkel L
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2198-206. PubMed ID: 25137423
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver.
Zhang A; Sieglaff DH; York JP; Suh JH; Ayers SD; Winnier GE; Kharitonenkov A; Pin C; Zhang P; Webb P; Xia X
J Endocrinol; 2015 Mar; 224(3):289-301. PubMed ID: 25501997
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 21 is not required for the reductions in circulating insulin-like growth factor-1 or global cell proliferation rates in response to moderate calorie restriction in adult mice.
Thompson AC; Bruss MD; Nag N; Kharitonenkov A; Adams AC; Hellerstein MK
PLoS One; 2014; 9(11):e111418. PubMed ID: 25369265
[TBL] [Abstract][Full Text] [Related]
19. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
20. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
